News | December 05, 2007

Doctors Prepare for Emergency Angioplasty

December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer laser face, according to an article in the Journal of Interventional Cardiology, researchers from the University of California , Davis Medical Center review state-of-the-art treatment for vessel punctures.

Catheters outfitted with balloons, lasers and miniature drills have made the treatment of blocked arteries virtually routine. Now physicians are using the same technology used to open clogged arteries to repair ruptures and perforations with less risk.

In the review, the authors describe several types of balloons, stents and coils. They urge physicians who perform angioplasty to become familiar with the supplies they stock in order to be prepared for an emergency. According to the researchers, an estimated 0.1 percent of patients undergoing balloon angioplasty, which uses an inflatable balloon to widen arteries, suffer a perforation during the procedure. Patients treated with a rotablator drill have a 1.3 percent risk of perforation, while those treated with the excimer laser face a 1.9 percent risk. Balloon, drill, and laser are all attached to a catheter inserted through a small incision in the arm or groin and snaked through an artery to the blockage.

“Rupture or perforation of a blood vessel during angioplasty can result in life-threatening bleeding,” said lead author John Laird, M.D. “This review provides doctors with a summary of equipment and techniques that will enhance their ability to treat such complications.”

Following a puncture, Laird and his colleagues first recommend inflating a balloon at the site to stem the bleeding. Then they suggest inserting embolization coils or a flexible tube called a stent graft to repair the vessel. Treatment also involves drug therapy to promote clotting.

Source: Journal of Interventional Cardiology (JIC)

For more information: www.invasivecardiology.com


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now